Literature DB >> 3512737

Suppression of immunoglobulin-secreting cells from human peripheral blood by toxic-shock-syndrome toxin-1.

N J Poindexter, P M Schlievert.   

Abstract

Toxic-shock syndrome toxin-1 (TSST-1), a nonspecific T lymphocyte mitogen, was shown to cause the suppression of immunoglobulin-secreting cells (ISCs) generated in pokeweed mitogen (PWM)-stimulated cultures of human peripheral blood mononuclear cells (PBMs). Greater than 90% suppression of the PWM-stimulated ISC response was achieved when 2 X 10(6) PBMs were cultured in the presence of 1 microgram of TSST-1. The nonspecific suppression induced by the toxin was dose related; amounts of TSST-1 as low as 1.0 ng/2 X 10(6) cultured cells caused significant suppression of the ISC response. TSST-1-induced suppression was due to the activation of a population of cells that secreted a soluble factor that mediated the resulting suppression. PBMs were activated by a 24-hr preincubation of 2 X 10(6) cells in the presence of 1 microgram of TSST-1 followed by repeated washing to remove residual toxin. These cells, when co-cultured with unstimulated PBMs and PWM, suppressed the normal ISC response. The supernatant factor, active at volumes of 10 microliters/2 X 10(6) PBMs, was generated by harvesting the supernatant fluid of TSST-1-activated cells. The results of these in vitro experiments confirm that TSST-1 is an immunosuppressing agent that affects human lymphocyte function and, in such a capacity, may play a role in the development of toxic shock syndrome in humans.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3512737     DOI: 10.1093/infdis/153.4.772

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  Immune response to staphylococcal superantigens.

Authors:  T Krakauer
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  Toxic shock syndrome.

Authors:  J K Todd
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

3.  Binding competition of toxic shock syndrome toxin 1 and other staphylococcal exoproteins for receptors on human peripheral blood mononuclear cells.

Authors:  R H See; G Krystal; A W Chow
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

4.  Nasopharyngeal infection by Streptococcus pyogenes requires superantigen-responsive Vβ-specific T cells.

Authors:  Joseph J Zeppa; Katherine J Kasper; Ivor Mohorovic; Delfina M Mazzuca; S M Mansour Haeryfar; John K McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-09       Impact factor: 11.205

5.  Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules.

Authors:  P Scholl; A Diez; W Mourad; J Parsonnet; R S Geha; T Chatila
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

6.  Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis.

Authors:  M F Hofer; K Newell; R C Duke; P M Schlievert; J H Freed; D Y Leung
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

7.  Induction of nitric oxide synthase activity by toxic shock syndrome toxin 1 in a macrophage-monocyte cell line.

Authors:  A Zembowicz; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

8.  Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins.

Authors:  P K Lee; J R Deringer; B N Kreiswirth; R P Novick; P M Schlievert
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

Review 9.  Staphylococcal and streptococcal superantigen exotoxins.

Authors:  Adam R Spaulding; Wilmara Salgado-Pabón; Petra L Kohler; Alexander R Horswill; Donald Y M Leung; Patrick M Schlievert
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 10.  Staphylococcal toxic shock syndrome: superantigen-mediated enhancement of endotoxin shock and adaptive immune suppression.

Authors:  Katarina Kulhankova; Jessica King; Wilmara Salgado-Pabón
Journal:  Immunol Res       Date:  2014-08       Impact factor: 4.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.